N/A
N=81
Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort
Chronic Venous Insufficiency
Bottom Line
View on ClinicalTrials.gov: NCT02015221 ↗Enrolled (actual)
81
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Ease of Use and Comfort for Subjects Using the ACTitouch System. — 70.8; 37.5; 89.2; 59.4 Percent of participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dual Action Pneumatic Compression Device (Device); Standard Compression Garments (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Tactile Medical
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ease of Use and Comfort for Subjects Using the ACTitouch System. |
70.8; 37.5; 89.2; 59.4; 70.8; 57.8 | — |
Summary
The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual action pneumatic compression device in patients with unilateral or bilateral chronic venous insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.
Eligibility Criteria
Inclusion Criteria
- Diagnosis of unilateral or bilateral CVI with or without leg ulcers
- Documented history of low adherence to compression garment therapy
- CEAP classification C3-C6
- Leg circumferences within the following ranges: Ankle 12-44cm, calf 22-6m, below the knee 22-68cm
Exclusion Criteria
- History of skin sensitivity to any of the components of ACTitouch or compression garments
- History of acute (deep vein thrombosis) DVT or (pulmonary embolism) PE within the last 3 months
- Ankle Brachial Index (ABI) 10%
- Exhibits any condition which, according to the PI, justifies the subjects exclusion from the study, such as a medical condition where an increase in venous or lymphatic return is undesirable.
- Subjects with open ulcers must be able to follow their care regimen for ulcer healing concurrently with the assigned study regimen.
- Participating in another clinical trial
- Changes to medications that affect edema within the last 30 days
- Currently pregnant or trying to become pregnant
Data sourced from ClinicalTrials.gov (NCT02015221). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.